Epothilone ZK-219477
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epothilone ZK-219477, covering 2012-09-24 to 2012-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma [Phase 2]